CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection-Reference-Cited by-同舟云学术

CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection

Published:2010-06-22 Issue:10 Volume:59 Page:1543-1549
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Yamada Noriyuki,Oizumi Satoshi,Kikuchi Eiki,Shinagawa Naofumi,Konishi-Sakakibara Jun,Ishimine Atsushi,Aoe Keisuke,Gemba Kenichi,Kishimoto Takumi,Torigoe Toshihiko,Nishimura Masaharu

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-010-0881-6.pdf

Reference37 articles.

1. Robinson BW, Musk AW, Lake RA (2005) Malignant mesothelioma. Lancet 366:397–408

2. Murayama T, Takahashi K, Natori Y, Kurumatani N (2006) Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model. Am J Ind Med 49:1–7

3. Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J (2005) The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer 92:587–593

4. Robinson BWS, Lake RA (2005) Advances in malignant mesothelioma. N Engl J Med 353:1591–1603

5. Sugerbaker DJ, Jaklitsch MT, Bueno R, Richards W, Lukanich J, Mentzer SJ, Colson Y, Linden P, Chang M, Capalbo L, Oldread E, Neragi-Miandoab S et al (2004) Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 128:138–146

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specific Imaging of CD8+ T-Cell Dynamics with a Nanobody Radiotracer against Human CD8β;2024-04-29

2. PI3Kα inhibitor GNE-493 triggers antitumor immunity in murine lung cancer by inducing immunogenic cell death and activating T cells;International Immunopharmacology;2024-03

3. Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream;Frontiers in Immunology;2024-01-08

4. [⁸⁹Zr]-CD8 ImmunoPET imaging of glioblastoma multiforme response to combination oncolytic viral and checkpoint inhibitor immunotherapy reveals CD8 infiltration differential changes in preclinical models;Theranostics;2024

5. Malignant and borderline mesothelial tumors of the pleura;Practical Pulmonary Pathology;2024